Medical term:

Avicidin

An investigational radioimmunotherapeutic agent for treating advanced therapeutically refractive cancers of the colon, ovarian and prostate, which delivers high-dose RT to metastatic tumours, while minimising exposure of normal tissues, especially bone marrow. Avicidin was discontinued in phase-II trials due to a high incidence of unacceptable diarrhea, which was atributed to cross-reactivity of the Avicidin anti-Epcam antibody with the intestine.

Latest Searches:
actinomycomata - acthib - acrospire - acrosin - acroscleroderma - acromiothoracic - acromioplasty - acrobystiolith - acrisorcin - AcQtrack - acorea - acoflex - acochoerus - acidogenic - acidity - acidimetries - acidimeter - achillotenotomy - achillodynia - acetylization -
- Service manuals - MBI Corp